Page last updated: 2024-10-22

amsacrine and Bone Diseases, Metabolic

amsacrine has been researched along with Bone Diseases, Metabolic in 1 studies

Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.

Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.

Research Excerpts

ExcerptRelevanceReference
"Amsacrine or cytarabine were administered subcutaneously in a dose of 3 mg/kg daily for four weeks."1.31[Effects of amsacrine and cytarabine on bones in rats]. ( Cegieła, U; Janiec, W, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cegieła, U1
Janiec, W1

Other Studies

1 other study available for amsacrine and Bone Diseases, Metabolic

ArticleYear
[Effects of amsacrine and cytarabine on bones in rats].
    Przeglad lekarski, 2000, Volume: 57, Issue:2

    Topics: Amsacrine; Animals; Antineoplastic Agents; Bone and Bones; Bone Density; Bone Diseases, Metabolic; C

2000